Skip to main content
Log in

Frusemide pretreatment blunts the inhibition of renal tubular sodium reabsorption by ANF in man

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The effects of atrial natriuretic factor (ANF) 15 pmol/kg/min on renal function were studied in 7 normal male volunteers during maximal water diuresis. Subjects were studied in neutral salt balance either before, or after, seven days treatment with 40 mg oral frusemide. The post-frusemide state was associated with activation of the renin-angiotensin system (RAAS) and generally higher noradrenaline levels; this state was also associated with sodium retention, mainly due to enhanced distal nephron reabsorption.

Without diuretic pretreatment ANF produced a natriuresis and diuresis associated with inhibition of both proximal and distal nephron sodium reabsorption. In contrast, after frusemide pretreatment, ANF caused an increase in water excretion (urinary flow rate) but no change in sodium excretion. In the post-diuretic condition ANF did not affect renal tubular handling of sodium.

The enhanced tubular reabsorption of sodium post-frusemide, and the failure of ANF to suppress this, could be due to activation of the RAAS and SNS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Biollaz J, Bidiville J, Diezi J, Waeber B, Nussberger J, Brunner-Ferber F, Gomez H, Brunner HR (1987) Site of action of synthetic atrial natriuretic peptide evaluated in humans. Kidney Int 32: 537–546

    Google Scholar 

  2. Brown J, Cott L (1987) Renal mechanisms of human α-atrial natriuretic peptide in man. J Physiol 387: 31–46

    Google Scholar 

  3. McMurray J, Seidelin PH, Struthers AD (1988) Evidence for a proximal and distal nephron action of atrial natriuretic factor in man. Naphron (in press)

  4. Johnston CI, Arnolda L, Tsunoda K, Hodsman P (1987) Atrial natriuretic factor in congestive heart failure. In: Brenner BM, Laragh JH (eds) Biologically active atrial peptides, vol 1. Raven Press, New York, pp 89–95

    Google Scholar 

  5. McMurray J, Struthers AD (1987) The role of neuroendocrine abnormalities in the enhanced sodium and water retention of chronic heart failure. Pharmacol Toxicol 61: 209–214

    Google Scholar 

  6. Morgan DA, Peuler JD, Koephe JP, DiBona GF, Mark AL (1986) The renal sympathetic nerves attenuate the natriuretic effects of atrial peptides. Clin Res 34: 937A

  7. Koephe JP, DiBona GF (1987) Blunted natriuresis due to atrial natriuretic peptide in chronic sodium retaining disorders. Am J Physiol 252: F865–871

    Google Scholar 

  8. McMurray J, Struthers AD (1988) Renal effects of angiotensin II, ANP and their interaction in man. J Hypertens 5: 559–562

    Google Scholar 

  9. Wilcox CS, Mitch WE, Kelly RA, Skorecki K, Meyer TW, Friedman PA, Souney PF (1983) Response of the kidney to furosemide I. Effects of salt intake and renal compensation. J Lab Clin Med 102: 450–458

    Google Scholar 

  10. Roberts CJC, Daneshmend TK (1981) Assessment of natriuretic drugs. Br J Clin Pharmac 12: 465–474

    Google Scholar 

  11. Brown MJ, Jenner DA (1981) Novel double-isotope technique for enzymatic assay of catecholamines, permitting high precision, sensitivity and plasma sample capacity. Clin Sci 61: 591–598

    Google Scholar 

  12. Kelly RA, Wilcox CS, Mitch WE, Meyer TW, Souney PF, Rayment CM, Friedman PA, Swartz (1983) Response of the kidney of furosemide II. Effect of captopril on sodium balance. Kidney Int 24: 233–239

    Google Scholar 

  13. Wilcox CS, Guzman NJ, Mitch WE, Kelly RA, Maroni BJ, Souney PF, Rayment CM, Braun L, Colucci R, Loon NR (1987) Na+, K+ and BP homeostasis in man during furosemide: Effects of prazosin and captopril. Kidney Int 31: 135–141

    Google Scholar 

  14. Weidman P, Hellmueller B, Uehlinger DE, Lang RE, Gnaedinger MP, Hasler L, Shaw S, Bachmann C (1986) Plasma levels and cardiovascular, endocrine and excretory effects of atrial natriuretic peptide during different sodium intakes in man. J Clin Endocrinol Metab 62: 1027–1036

    Google Scholar 

  15. Cuneo RC, Espiner EA, Nicholls MG, Yandle TG, Joyce SL, Gilchrist NL (1986) Renal, haemodynamic and hormonal responses to atrial natriuretic peptide infusions in normal man and effect of sodium intake. J Clin Endocrinol Metab 63: 946–953

    Google Scholar 

  16. Gaillard CA, Koomans HA, Boer WH, Boer P, Dorhout-Mers EJ (1987) Atrial natriuretic peptide and sodium intake: Blunted effects in the normal sodium-retaining kidney. Neth J Med 30: 10–16

    Google Scholar 

  17. Solomon LR, Atherton JC, Bobinski H, Green R (1987) Effect of dietary sodium chloride and posture on plasma immunoreactive atrial natriuretic peptide concentrations in man. Clin Sci 72: 201–208

    Google Scholar 

  18. McMurray J, Struthers AD (1988) Arginine vasopressin dissociates the natriuresis and diuresis due to ANF in man. Br J Clin Pharmacol (in press)

  19. Freeman RH, Davis JO, Vari RC (1984) Renal response to atrial natriuretic factor in conscious dogs with caval constriction. Am J Physiol 248: R495-R500

    Google Scholar 

  20. Bayliss J, Norell M, Canepa-Anson R, Sutton G, Poole-Wilson P (1987) Untreated heart failure: Clinical and neuroendocrine effects of introducing diuretics. Br Heart J 57: 17–22

    Google Scholar 

  21. Francis GS, Goldsmith SR, Levine TB, Olivari MT, Cohn JN (1984) The neurohumoral axis in congestive heart failure. Ann Int Med 101: 370–377

    Google Scholar 

  22. Crozier IG, Nicholls MG, Ikram H, Espiner EA, Gomez HJ, Warner NJ (1986) Haemodynamic effects of atrial peptide infusion in heart failure. Lancet 2: 1242–1245

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

McMurray, J., Struthers, A.D. Frusemide pretreatment blunts the inhibition of renal tubular sodium reabsorption by ANF in man. Eur J Clin Pharmacol 35, 333–338 (1988). https://doi.org/10.1007/BF00561360

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00561360

Key words

Navigation